A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study was a randomized, single dose crossover comparison of the investigational product
with a Reference Product (vinorelbine tartrate injection, NAVELBINE®). The primary objective
was to demonstrate the equivalence of ANX-530 and the Reference Product, NAVELBINE.